Sections View Full Chapter Figures Tables Videos Annotate Full Chapter Figures Tables Videos Supplementary Content +++ Key Features ++ Erythema multiforme has sometimes been diagnosed in patients with severe mucous membrane involvement, but Stevens-Johnson syndrome is the diagnosis when severe involvement of conjunctiva, oral cavity, and genital mucosa also occur Many causes are suspected, particularly concomitant herpes simplex virus (HSV); drugs, especially sulfonamides; and Mycoplasma infections Recurrent erythema multiforme is usually associated with reactivation of HSV In erythema multiforme, spontaneous healing occurs in 10–14 days, but Stevens-Johnson syndrome may last 6–8 weeks +++ Clinical Findings ++ Papules that later develop a dark center Lesions with central bluish discoloration or blisters Characteristic target lesions (iris lesions) that have three concentric circles of color change +++ Diagnosis ++ Clinical +++ Treatment ++ Treatment is symptomatic in uncomplicated erythema multiforme Discontinue offending drugs Oral antihistamines such as cetirizine 5–10 mg every morning and hydroxyzine 1 mg/kg/d at bedtime are useful Cool compresses and wet dressings relieve pruritus Corticosteroids have not been demonstrated to be effective Long-term acyclovir therapy has been successful in decreasing attacks in patients with HSV-associated recurrent erythema multiforme Your Access profile is currently affiliated with [InstitutionA] and is in the process of switching affiliations to [InstitutionB]. Please select how you would like to proceed. Keep the current affiliation with [InstitutionA] and continue with the Access profile sign in process Switch affiliation to [InstitutionB] and continue with the Access profile sign in process Get Free Access Through Your Institution Learn how to see if your library subscribes to McGraw Hill Medical products. Subscribe: Institutional or Individual Sign In Error: Incorrect UserName or Password Username Error: Please enter User Name Password Error: Please enter Password Sign in Forgot Password? Forgot Username? Sign in via OpenAthens Sign in via Shibboleth You already have access! Please proceed to your institution's subscription. Create a free profile for additional features.